You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 113 No. 9, September 1995 TABLE OF CONTENTS
  Archives
  •  Online Features
  Epidemiology and Biostatistics
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Biochemical Factors in the Lens Opacities Case-Control Study

M. Cristina Leske, MD, MPH; Suh-Yuh Wu, MA; Leslie Hyman, PhD; Robert Sperduto, MD; Barbara Underwood, PhD; Leo T. Chylack, MD; Roy C. Milton, PhD; Satish Srivastava, PhD; Naseem Ansari, PhD; The Lens Opacities Case-Control Study Group

Arch Ophthalmol. 1995;113(9):1113-1119.


Abstract

Objective
To evaluate associations with biochemical indicators of nutritional and other risk factors in the Lens Opacities Case-Control Study.

Design
Case-control study.

Setting and Participants
The Lens Opacities CaseControl Study determined risk factors for cortical, nuclear, and posterior subcapsular opacities among 1380 participants aged 40 to 79 years.

Data Collection
Vitamin E, selenium, and biochemistry profile determinations were performed on all patients; red blood cell enzymes and amino acids were measured in systematic samples of about25% of the Lens Opacities Case-Control Study population.

Outcome
Laboratory test values in cases and controls were compared and expressed as odds ratios and 95% confidence intervals.

Results
In polychotomous logistic regression analyses controlling for age and sex, the risk of opacities was reduced to less than one half in persons with higher levels of vitamin E (odds ratio, 0.44 for nuclear opacities), albumin-globulin ratio (odds ratio, 0.41 for mixed opacities), or iron (odds ratio, 0.43 for cortical opacities); higher uric acid levels increased risk (odds ratio, 1.74 for mixed opacities). Persons with opacities were twice as likely to have high glutathione reductase activity (with flavin adenine dinucleotide), which suggests low riboflavin status (odds ratio, 2.13). Most odds ratios for amino acids were under unity and were significantly decreased for glycine (0.36) and aspartic acid (0.31).

Conclusions
Lens opacities were associated with lower levels of riboflavin, vitamin E, iron, and protein nutritional status. Higher levels of uric acid increased risk of mixed opacities. The findings for riboflavin, vitamin E, iron, and uric acid are compatible with the dietary intake and medical history results of the Lens Opacities Case-Control Study.



Author Affiliations

From the Division of Epidemiology, Department of Preventive Medicine, State University of New York at Stony Brook (Drs Leske and Hyman and Ms Wu); Office of Biometry and Epidemiology, National Eye Institute, Bethesda, Md (Drs Sperduto and Milton); World Health Organization, Geneva, Switzerland (Dr Underwood); Department of Ophthalmology, Harvard Medical School and the Division of Ophthalmology, Department of Surgery, Brigham and Women's Hospital, Boston, Mass (Dr Chylack); and Division of Human Genetics, Department of Human Biological Chemistry and Genetics, University of Texas Medical Branch, Galveston (Drs Srivastava and Ansari). Members of The Lens Opacities Case-Control Study Group are listed in Archives of Ophthalmology (1991;109:251).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Prospective Epidemiological Cohort Study of Reduced Risk for Incident Cataract with Vigorous Physical Activity and Cardiorespiratory Fitness during a 7-Year Follow-up
Williams
IOVS 2009;50:95-100.
ABSTRACT | FULL TEXT  

Blood Levels of Vitamin C, Carotenoids and Retinol Are Inversely Associated with Cataract in a North Indian Population
Dherani et al.
IOVS 2008;49:3328-3335.
ABSTRACT | FULL TEXT  

The Antioxidants in Prevention of Cataracts Study: effects of antioxidant supplements on cataract progression in South India
Gritz et al.
Br J Ophthalmol 2006;90:847-851.
ABSTRACT | FULL TEXT  

Statin Use and Incident Nuclear Cataract
Klein et al.
JAMA 2006;295:2752-2758.
ABSTRACT | FULL TEXT  

Long-term Nutrient Intake and 5-Year Change in Nuclear Lens Opacities
Jacques et al.
Arch Ophthalmol 2005;123:517-526.
ABSTRACT | FULL TEXT  

Albumin and Transthyretin as Risk Factors for Cataract: The POLA Study
Delcourt et al.
Arch Ophthalmol 2005;123:225-232.
ABSTRACT | FULL TEXT  

Low Vitamin E Level as a Subliminal Risk Factor in a Rat Model of Prednisolone-Induced Cataract
Kojima et al.
IOVS 2002;43:1116-1120.
ABSTRACT | FULL TEXT  

Long-term intake of vitamins and carotenoids and odds of early age-related cortical and posterior subcapsular lens opacities
Taylor et al.
Am. J. Clin. Nutr. 2002;75:540-549.
ABSTRACT | FULL TEXT  

A Randomized, Placebo-Controlled, Clinical Trial of High-Dose Supplementation With Vitamins C and E and Beta Carotene for Age-Related Cataract and Vision Loss: AREDS Report No. 9
Age-Related Eye Disease Study Research Group
Arch Ophthalmol 2001;119:1439-1452.
ABSTRACT | FULL TEXT  

Relations of body fat distribution and height with cataract in men
Schaumberg et al.
Am. J. Clin. Nutr. 2000;72:1495-1502.
ABSTRACT | FULL TEXT  

Serum carotenoids and tocopherols and incidence of age-related nuclear cataract
Lyle et al.
Am. J. Clin. Nutr. 1999;69:272-277.
ABSTRACT | FULL TEXT  

Prevalence of Lens Opacities in the Barbados Eye Study
Leske et al.
Arch Ophthalmol 1997;115:105-111.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1995 American Medical Association. All Rights Reserved.